Todos Medical Ltd. – OTC:TOMDF

Todos Medical Ltd. stock price today

$0.001
+0.00
+7900%
Financial Health
0
1
2
3
4
5
6
7
8
9

Todos Medical Ltd. stock price monthly change

-100.00%
month

Todos Medical Ltd. stock price quarterly change

-100.00%
quarter

Todos Medical Ltd. stock price yearly change

-100.00%
year

Todos Medical Ltd. key metrics

Market Cap
6.75M
Enterprise value
37.47M
P/E
-0.03
EV/Sales
3.48
EV/EBITDA
-2.24
Price/Sales
0.15
Price/Book
-0.05
PEG ratio
N/A
EPS
N/A
Revenue
N/A
EBITDA
N/A
Income
N/A
Revenue Q/Q
-100%
Revenue Y/Y
-86.94%
Profit margin
-360.67%
Oper. margin
-30.65%
Gross margin
41.66%
EBIT margin
-30.65%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Todos Medical Ltd. stock price history

Todos Medical Ltd. stock forecast

Todos Medical Ltd. financial statements

Todos Medical Ltd. (OTC:TOMDF): Profit margin
Dec 2022 1.40M -4.99M -355.88%
Mar 2023 0 0
Jun 2023 0 0
Sep 2023 0 0
Todos Medical Ltd. (OTC:TOMDF): Debt to assets
Sep 2022 14227000 44.86M 315.33%
Mar 2023 0 0
Jun 2023 0 0
Sep 2023 0 0
Todos Medical Ltd. (OTC:TOMDF): Cash Flow
Dec 2022 -796.96K 12.31K 763.4K
Mar 2023 0 0 0
Jun 2023 0 0 0
Sep 2023 0 0 0

Todos Medical Ltd. alternative data

Todos Medical Ltd. (OTC:TOMDF): Employee count
Aug 2023 7
Sep 2023 7
Oct 2023 7
Nov 2023 7
Dec 2023 7
Jan 2024 7
Feb 2024 7
Mar 2024 7
Apr 2024 7
May 2024 7
Jun 2024 7
Jul 2024 7

Todos Medical Ltd. other data

Todos Medical Ltd. (OTC:TOMDF): Insider trades (number of shares)
Period Buy Sel
Aug 2022 1000000 0
Mar 2023 5000000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
COMMISSIONG GERALD director, officer: CEO and Dire..
Ordinary Shares 5,000,000 $0 $5,000
Purchase
COMMISSIONG GERALD director, officer: CEO and Dire..
Ordinary Shares 1,000,000 $0.03 $32,000
Purchase
COMMISSIONG GERALD director, officer: CEO and Dire..
Ordinary Shares 1,051,480 $0.03 $35,750
Sale
STRATEGIC INVESTMENT HOLDINGS, LLC 10 percent owner
Common Stock 1,724,139 $0.08 $132,759
Sale
STRATEGIC INVESTMENT HOLDINGS, LLC 10 percent owner
Common Stock 1,149,425 $0.08 $88,506
Sale
STRATEGIC INVESTMENT HOLDINGS, LLC 10 percent owner
Common Stock 100,000 $0.06 $5,700
Sale
STRATEGIC INVESTMENT HOLDINGS, LLC 10 percent owner
Common Stock 150,000 $0.05 $8,100
Sale
STRATEGIC INVESTMENT HOLDINGS, LLC 10 percent owner
Common Stock 100,000 $0.06 $5,600
Sale
STRATEGIC INVESTMENT HOLDINGS, LLC 10 percent owner
Common Stock 98,300 $0.06 $5,505
Sale
STRATEGIC INVESTMENT HOLDINGS, LLC 10 percent owner
Common Stock 100,000 $0.05 $5,300
Insider Compensation
Mr. Gerald E. Commissiong (1983) Chief Executive Officer, Pres & Director
$183,330
Mr. Daniel Hirsch (1969) Chief Financial Officer & Director $120,830
Friday, 22 December 2023
globenewswire.com
Tuesday, 26 September 2023
globenewswire.com
Wednesday, 30 August 2023
globenewswire.com
Tuesday, 28 March 2023
Proactive Investors
Wednesday, 15 March 2023
Proactive Investors
Thursday, 23 February 2023
Proactive Investors
Tuesday, 14 February 2023
Proactive Investors
Tuesday, 6 December 2022
GlobeNewsWire
Wednesday, 16 November 2022
Proactive Investors
Tuesday, 15 November 2022
Proactive Investors
Monday, 14 November 2022
GlobeNewsWire
Friday, 14 October 2022
Proactive Investors
Tuesday, 11 October 2022
Proactive Investors
Thursday, 6 October 2022
Proactive Investors
Friday, 30 September 2022
Proactive Investors
Tuesday, 27 September 2022
Proactive Investors
Thursday, 22 September 2022
Proactive Investors
Friday, 16 September 2022
Proactive Investors
Wednesday, 14 September 2022
Proactive Investors
Monday, 12 September 2022
Proactive Investors
Wednesday, 31 August 2022
Proactive Investors
Monday, 29 August 2022
Proactive Investors
Friday, 26 August 2022
Proactive Investors
Tuesday, 23 August 2022
Proactive Investors
Proactive Investors
Monday, 22 August 2022
GlobeNewsWire
Proactive Investors
Thursday, 11 August 2022
Proactive Investors
Proactive Investors
Wednesday, 10 August 2022
Proactive Investors
  • What's the price of Todos Medical Ltd. stock today?

    One share of Todos Medical Ltd. stock can currently be purchased for approximately $0.

  • When is Todos Medical Ltd.'s next earnings date?

    Unfortunately, Todos Medical Ltd.'s (TOMDF) next earnings date is currently unknown.

  • Does Todos Medical Ltd. pay dividends?

    No, Todos Medical Ltd. does not pay dividends.

  • How much money does Todos Medical Ltd. make?

    Todos Medical Ltd. has a market capitalization of 6.75M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 37.08% to 7.7M US dollars.

  • What is Todos Medical Ltd.'s stock symbol?

    Todos Medical Ltd. is traded on the OTC under the ticker symbol "TOMDF".

  • What is Todos Medical Ltd.'s primary industry?

    Company operates in the Healthcare sector and Diagnostics & Research industry.

  • How do i buy shares of Todos Medical Ltd.?

    Shares of Todos Medical Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Todos Medical Ltd.'s key executives?

    Todos Medical Ltd.'s management team includes the following people:

    • Mr. Gerald E. Commissiong Chief Executive Officer, Pres & Director(age: 42, pay: $183,330)
    • Mr. Daniel Hirsch Chief Financial Officer & Director(age: 56, pay: $120,830)
  • How many employees does Todos Medical Ltd. have?

    As Jul 2024, Todos Medical Ltd. employs 7 workers.

  • When Todos Medical Ltd. went public?

    Todos Medical Ltd. is publicly traded company for more then 8 years since IPO on 24 Aug 2017.

  • What is Todos Medical Ltd.'s official website?

    The official website for Todos Medical Ltd. is todosmedical.com.

  • How can i contact Todos Medical Ltd.?

    Todos Medical Ltd. can be reached via phone at +972 52 642 0126.

Todos Medical Ltd. company profile:

Todos Medical Ltd.

todosmedical.com
Exchange:

OTC

Full time employees:

7

Industry:

Diagnostics & Research

Sector:

Healthcare

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

1 Hamada Street
Rehovot, 6701203

CIK: 0001645260
ISIN: IL0011392375
: